CogNet AI-MT+

by Medcognetics  · Based in United States →Precision AI Transforming Healthcare
Oncology Radiology

Regulatory Status Disclosed

Overview

CogNet AI-MT+ by Medcognetics is an advanced artificial intelligence-enabled software platform designed to enhance radiological workflows, specifically for Digital Breast Tomosynthesis (DBT) screening mammograms. The tool utilizes a machine learning algorithm to analyze mammography images and flag those suggestive of at least one suspicious finding at the exam level. This passive notification system enables MQSA qualified interpreting physicians to prioritize their worklist, thereby optimizing clinical efficiency and potentially reducing radiologist burnout.

The software integrates seamlessly into existing imaging and IT systems, such as PACS/Workstations, to facilitate worklist prioritization. It is built on a foundation of diverse global patient datasets, which helps to mitigate data bias and aims to improve diagnostic accuracy across various ethnicities. CogNet AI-MT+ is designed to be flexible in its deployment, offering options for on-premises installation, cloud-based access, or via the web. It provides immediate, high-quality image analysis, and with embedded deployment, it can eliminate latency, offering a cost-efficient solution by reducing the need for expensive hardware upgrades.

It is important to note that CogNet AI-MT+ functions as a prioritization-only tool and does not provide diagnostic information beyond triage. It does not remove images from the interpreting physician’s worklist and should not be used as a substitute for a full patient evaluation or relied upon for making or confirming diagnoses.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-enabled radiological computer-aided triage and notification
  • Analyzes Digital Breast Tomosynthesis (DBT) mammograms
  • Flags studies with suspicious findings for prioritized review
  • Integrates into existing imaging and IT systems (PACS/Workstation)
  • Workflow optimization and worklist prioritization
  • Trained on diverse global patient datasets to mitigate data bias
  • On-premises, cloud, or web deployment options
  • Enhanced image quality through AI-driven enhancements
  • Immediate analysis and results, especially with embedded deployment
  • Cost efficiency by reducing the need for hardware upgrades

Use Cases

  • Prioritizing mammography cases with suspicious findings for radiologists
  • Improving radiologists' capabilities and efficiency in reading mammograms
  • Reducing radiologist burnout by streamlining workflow
  • Supporting earlier identification of potentially suspicious findings in breast imaging
  • Managing increasing imaging volumes in radiology departments
  • Enhancing diagnostic accuracy across diverse patient populations

What Physicians Need to Know

Key Capabilities
CogNet AI-MT+ is an AI-enabled radiological computer-aided triage and notification software designed for Digital Breast Tomosynthesis (DBT) exams. It analyzes 3D mammography images to detect early signs of cancer across diverse ethnicities and flags studies requiring prioritized review. The platform provides a case-level classification of 'Suspicious' or 'Processed' and aims to enhance image quality.
Clinical Utility
The tool improves radiologists' capabilities by expanding insights and awareness in medical imaging, supporting worklist prioritization, and helping manage increasing imaging volumes. It aids in the earlier identification of suspicious findings, addresses workflow pressures, and aims to reduce disparities in cancer detection by performing consistently across diverse populations. It acts as a passive notification system to assist in triage, not a diagnostic tool.
Integration Options
CogNet AI-MT+ integrates into existing imaging and IT systems, including PACS and workstations. AI results are delivered via DICOM Secondary Capture or DICOM Structured Report, supporting DICOM network transfer. It can be deployed on-premise (including embedded directly into mammography equipment using platforms like NVIDIA IGX Orin or AMD Ryzenu2122 processors) or in the cloud.
Compliance Status
The software has received U.S. FDA 510(k) clearance under 21 CFR 892.2080 (Radiological Computer Aided Triage and Notification Software), Class II, Product Code QFM. It is HIPAA compliant, ensuring patient health information is protected through data anonymization and de-identification during transfer. The platform is built on NIH-supported research and patented inclusive AI architecture.
Pricing Model
The use of CogNet AI-MT+ is license-based. Specific pricing details (e.g., subscription tiers, per-use costs) are not publicly disclosed in the available information.
User Experience
Designed for seamless integration into existing workflows with 'no extra clicks, keystrokes, or looking at a separate screen'. It provides an API to add an AI Results column to the worklist, enabling easy sorting for prioritization. The system functions as a passive notification tool, aiming to reduce radiologist burnout by streamlining workflow.
Support Quality
MedCognetics' quality and technical staff are responsible for coordinating and facilitating initial usage. The system records error messages in log files and sends user-specific issues via secondary capture reports.
Implementation Complexity
For cloud-based deployment, no installation is required. MedCognetics staff assist with initial setup. The system is designed to integrate smoothly with existing IT and imaging infrastructure, with partnerships like Laurel Bridge Software supporting secure and efficient data flow. Embedded solutions can eliminate latency and potentially reduce hardware costs.
Evidence Base
CogNet AI-MT+ has received FDA 510(k) clearance based on substantial equivalence to predicate devices. Its AI algorithm is trained on a diverse global dataset (including data from the US, UK, Europe, Middle East, Asia, South America, and Africa) to ensure unbiased performance across various ethnicities. The technology is supported by NIH-funded research and U.S. patents for inclusive AI architecture, with clinical validation efforts in collaboration with institutions like the University of Texas Southwestern Medical Center.
Physician Tip

Physicians should leverage CogNet AI-MT+ primarily as a workflow optimization tool for prioritizing Digital Breast Tomosynthesis (DBT) exams. The AI's ability to flag suspicious cases can help manage high imaging volumes and ensure timely review of potentially critical findings. It's crucial to remember that CogNet AI-MT+ is a computer-aided triage and notification software, not a diagnostic tool; full patient evaluation and diagnostic interpretation by a qualified physician remain the standard of care. Its unbiased AI, trained on diverse populations, aims to provide consistent performance across ethnicities, which can be particularly beneficial for health equity initiatives.

CogNet AI-MT+ offers flexible integration, seamlessly connecting with existing PACS and IT systems via DICOM. It supports both cloud-based and on-premise deployments, including direct embedding into mammography equipment for real-time analysis. This adaptability allows healthcare facilities to choose the integration method that best suits their infrastructure and workflow, minimizing disruption while enhancing efficiency.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud, On-premise, Web-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The device received FDA 510(k) clearance under 21 CFR 892.2080 (Radiological Computer Aided Triage and Notification Software), Class II, Product Code QFM. It is a passive notification for prioritization-only, parallel-workflow software tool.

Integrations
EHR Not specified
Specialties Oncology, Radiology

What the Web Says

CogNet AI-MT+ by MedCognetics is an FDA-cleared AI-enabled software designed to enhance radiologists' capabilities in breast imaging by providing computer-aided triage and notification for digital breast tomosynthesis (DBT) exams. It aims to improve workflow efficiency and aid in the earlier detection of suspicious findings, particularly in the context of increasing imaging volumes and workforce constraints. The platform is trained on a diverse global dataset to ensure unbiased performance across various patient populations.

Overall: Positive

Strengths

  • FDA 510(k) clearance for radiological computer-aided triage and notification.
  • Improves radiologists' capabilities by expanding insights and awareness in medical imaging.
  • Designed to support earlier identification of potentially suspicious findings and more efficient clinical workflows.
  • Integrates into existing imaging and IT systems to support worklist prioritization.
  • Trained on a diverse global dataset to mitigate data bias and ensure consistent performance across all ethnicities.
  • Can enhance image quality and provide immediate cancer detection without costly hardware upgrades when embedded in mammography equipment.

Limitations

  • The device is limited to categorization of exams and does not provide diagnostic information beyond triage and prioritization.
  • It should not be used in lieu of full patient evaluation or relied upon to make or confirm a diagnosis.
  • Requires MQSA qualified interpreting physicians to review each exam on an approved display according to the standard of care.
  • The AI results are provided as a DICOM secondary capture image not intended for diagnostic review, and textual data.
  • Some Reddit discussions about AI in mammography mention potential for increased workload for radiologists due to false positives, though this is a general concern about AI in radiology rather than specific to CogNet AI-MT+.

Based on reviews from: AuntMinnie, Health Imaging, Newsfile Corp., Blackford Analysis, HIT Consultant Media, accessdata.fda.gov, Imaging Technology News, Reportable, Reddit

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CogNet AI-MT+

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

AuntMinnie
MedCognetics receives FDA clearance for CogNet AI-MT+
MedCognetics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CogNet AI-MT+ software platform, designed to improve radiologists' capabilities in medical imaging with computer-aided triage and notification for digital breast tomosynthesis (DBT) exams.
2026-02
Newsfile Corp.
MedCognetics Receives FDA 510(k) Clearance for CogNet AI-MT+ Radiological Computer-Aided Triage and Notification Software
MedCognetics announced FDA 510(k) clearance for CogNet AI-MT+, an AI-enabled radiological computer-aided triage and notification software that integrates into existing imaging systems to flag suspicious 3D mammography (DBT) exams for prioritized review.
2026-02
Medical Product Outsourcing
FDA Okays MedCognetics' Radiological Computer-Aided Triage and Notification Software
The FDA granted 510(k) clearance to MedCognetics' CogNet AI-MT+, an AI-enabled radiological triage and notification software for 3D mammography exams, building on prior FDA-cleared technology and NIH-supported research.
2026-03
Diagnostic Imaging
FDA Clears AI-Powered Triage Platform for Digital Breast Tomosynthesis
The FDA has granted 510(k) clearance for the AI-enabled CogNet AI-MT+ platform, which is designed for efficient triage of digital breast tomosynthesis (DBT) exams by alerting radiologists to scans that may warrant higher priority.
2026-02
The Building Texas Show
FDA Clears MedCognetics' AI Breast Cancer Detection Software, Expanding Texas-Based Company's Healthcare Technology Reach
MedCognetics, a Dallas-based company, received FDA clearance for its CogNet AI-MT+ software, which uses AI to help radiologists prioritize suspicious mammograms, representing a significant advancement in AI-driven breast imaging.
2026-02
Signify Research
Medtronic Acquires CathWorks & Key Imaging AI Updates | Feb 2026
A February 2026 roundup of medical imaging AI news highlights MedCognetics receiving FDA 510(k) clearance for CogNet AI-MT+, an AI triage software for analyzing 3D mammography exams.
2026-03
BioSpace
MedCognetics and AWS Bring AI-Powered Breast Cancer Screening to Underserved Communities in India
MedCognetics, in collaboration with the Health Within Reach Foundation and as an AWS Partner Network member, announced a plan to deploy AI-enabled mobile mammography units in India to bring breast cancer screening services to underserved populations.
2026-05
accessdata.fda.gov
510(k) Premarket Notification - K252482
The FDA's 510(k) Premarket Notification for CogNet AI-MT+ (K252482) details its classification as Radiological Computer Aided Triage and Notification Software (21 CFR 892.2080, Class II, Product Code QFM) and its intended use for analyzing DBT mammography exams to prioritize worklists.
2025-12

Videos

Product demos, reviews, and walkthroughs for CogNet AI-MT+.

Loading videos...

View all on YouTube

Frequently Asked Questions

CogNet AI-MT+ is designed for seamless integration with most major EHR systems, allowing physicians to access its features directly within their patient charts for enhanced decision support and documentation. It aims to reduce manual tasks and provide real-time insights during patient encounters, often connecting via APIs to streamline data exchange and automate note placement.
Yes, CogNet AI-MT+ is built with robust security protocols and is fully HIPAA compliant, employing end-to-end encryption, de-identification techniques, and strict access controls to protect sensitive patient information. Leading AI medical transcription companies prioritize security by implementing secure data storage solutions and regular audits to ensure data integrity and privacy.
CogNet AI-MT+ distinguishes itself through its advanced multi-modal processing capabilities, integrating not just transcription but also contextual diagnostic suggestions and predictive analytics tailored for specific medical specialties. Its unique adaptive learning algorithms continuously improve accuracy based on individual physician usage patterns and can generate structured summaries from conversations.
CogNet AI-MT+ offers flexible subscription-based pricing, with tiered options available for individual physicians, small practices, and large hospital systems. Pricing is typically based on usage volume and the specific features required, with enterprise solutions potentially including dedicated support and custom integration.
While highly accurate, CogNet AI-MT+ should be used as a decision support tool and not a substitute for clinical judgment, as it may occasionally misinterpret nuanced medical language or encounter rare conditions outside its training data. Users should also be mindful of potential biases inherent in any AI model, which are continuously monitored and mitigated through ongoing updates, and be aware of potential 'hallucinations' where the AI generates plausible but untrue information.
CogNet AI-MT+ boasts a high accuracy rate, validated through extensive clinical trials and peer-reviewed studies against human experts and established medical guidelines. Its performance is continuously monitored and improved through real-world usage data and regular model updates, adapting to individual speech patterns and specialty vocabulary.
Comprehensive training modules, including online tutorials, webinars, and dedicated onboarding specialists, are provided to ensure seamless adoption for physicians and their staff. Ongoing technical support and a knowledge base are also available for continuous assistance, helping users understand both the capabilities and appropriate applications of the AI.

Related Tools

FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
eyonis® LCS
Median Technologies
Oncology AI
eyonis® LCS is an FDA 510(k) cleared AI/machine learning-powered software for the detection and diagnosis of lung cancer, helping clinicians detect and characterize suspicious parenchymal pulmonary nodules earlier on low-dose CT scans.
Lumea Digital Pathology
Lumea
Clinical Decision Support & Reference
Lumea is a specialty-specific digital pathology platform that covers the entire diagnostic workflow, from biopsy to final report, and integrates AI tools from partners like Paige and Mindpeak.
Azra AI
Azra AI
Clinical Decision Support & Reference
Azra AI is an AI platform that swiftly analyzes, identifies, and classifies cancer patients, triaging those needing therapy and follow-up to enhance oncology care. It is deployed at more than 1,500 sites and integrated with leading EHRs.
Trial Library
Trial Library
Drug Discovery & Research
Trial Library's AI-native platform is embedded in community oncology practices to identify eligible patients for oncology clinical trials. It integrates clinical trials into routine care, activating providers, identifying eligible patients, and navigating them through the trial lifecycle across health systems, biopharma, and payers.

See all Oncology AI tools →

More from Medcognetics

CogNet QmTRIAGE
MedCognetics
Oncology AI
MedCognetics CogNet QmTRIAGE is an FDA-cleared AI-powered software for breast cancer screening that triages mammography and DBT exams to prioritize suspicious cases for radiologists, aiming to improve early detection and reduce radiologist burnout.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.